3
<Applicant> <Address> <Address> <Post code> <Town> <Country> <Date> <Reference> <National Agency> <Address> <Address> <Post code> <Town> <Country> Subject : Submission of Variation Application Dossier(s) for <Product Name(s) in the MS where the application(s) for variation is submitted> <Procedure Number(s)> Dear Sirs, We are pleased to submit our Variation Application Dossier(s) for <Type IA IN / Type IA / Type IB unforeseen / Type IB foreseen / Type II > Procedure(s). The application concerns <Single variation / Grouping of variations / Grouping of variations including a line extension / Worksharing>. The details are as follows: Name of the medicinal product(s) ( in the RMS): .......................... Pharmaceutical form(s) and strength(s): ……………………………………………......... INN/active substance(s): ………………… ATC Code(s): ............. National Marketing Authorisation Number(s): ....................................................................... ........................ Type of the Variation Application(s): ................................... Cover Letter Variation Submission Dossier June 2012, Rev.1 <Procedure Number> <Product Name> Page 1/3

CMDh-096-2009-Rev2_06_2012.doc

Embed Size (px)

Citation preview

Page 1: CMDh-096-2009-Rev2_06_2012.doc

<Applicant><Address><Address><Post code> <Town><Country>

<Date><Reference>

<National Agency><Address><Address><Post code> <Town><Country>

Subject: Submission of Variation Application Dossier(s) for <Product Name(s) in the MS where the application(s) for variation is submitted> <Procedure Number(s)>

Dear Sirs,

We are pleased to submit our Variation Application Dossier(s) for <Type IAIN / Type IA / Type IB unforeseen / Type IB foreseen / Type II > Procedure(s).

The application concerns <Single variation / Grouping of variations / Grouping of variations including a line extension / Worksharing>.

The details are as follows:

Name of the medicinal product(s) (in the RMS): ............................................................................................Pharmaceutical form(s) and strength(s): …………………………………………….....................................INN/active substance(s):.....………………… ATC Code(s): .......................................National Marketing Authorisation Number(s):

...............................................................................................

Type of the Variation Application(s): ...............................................................................................................When appropriate, please indicate type of change (for Type IB and Type II variations only):

IndicationPaediatric IndicationSafety

Following Urgent Safety RestrictionQualityAnnual variation for human influenza vaccinesOther

Cover Letter Variation Submission DossierJune 2012, Rev.1 <Procedure Number> <Product Name> Page 1/3

Page 2: CMDh-096-2009-Rev2_06_2012.doc

You will find enclosed with the submission dossier the documentation hereafter:If the submission dossier is provided electronically,

eCTD format Sequence number: < Four digit number >

NeeS format Submission number (if used): < Four digit number >

- <Number> media units per application and <number> copies are provided.

Sequence Tracking Table is attached (mandatory for eCTD, recommended for NeeS)

We confirm that all future submissions for this specific product will be submitted in this same format (NeeS format may be upgraded to eCTD later).

The <eCTD><NeeS> has passed the applicant’s internal technical validation (all P/F criteria) and all BP criteria have been fulfilled up to our best knowledge using <name and version number of the validation software>

- The submission is checked with an up-to-date and state-of-the-art virus checker The dossier is submitted in paper format (Note: Full paper dossiers can only be submitted to NCAs still accepting paper

submissions and should only be used exceptionally when a valid electronic format dossier really could not be provided.) An identical electronic copy of the paper dossier is also provided

Number of paper binders provided:- Module 1: <xx> enclosures- Module 2: <xx> enclosures- Module 3: <xx> enclosures- Module 4: <xx> enclosures- Module 5: <xx> enclosures

Different formats (eCTD, NeeS, other electronic or paper) are submitted to different RMS/CMS (specify differences to different NSAs in text below): (This is not recommended and requires an explanation if needed.)

<Text field>

<- Multiple/duplicate variation applications are submitted.>1

<- The relevant fees have been paid.>

The dispatch list is appended (to RMS only). The dispatch list will be forwarded to the RMS as soon as the application has been submitted to all CMS.

<Free text field – when appropriate and if important for the validation of the application(s) additional information can be provided e.g. location of Notes to Reviewers, National file number if provided before submission etc.>

We, <Applicant>, finally hereby certify that the dossiers submitted to the RMS and CMS(s) are identical.

There are, however, some different national documents <cover letter><application form><specific national requirements> that are submitted to the relevant RMS/CMS only, outside the eCTD/NeeS dossier

There are, however, some different national documents <cover letter><application form><specific national requirements> that are submitted to the relevant RMS/CMS only, within the eCTD/NeeS dossier

1 When duplicates are submitted, a reference to the first application should be given.

Cover Letter Variation Submission DossierJune 2012, Rev.1 <Procedure Number> <Product Name> Page 2/3

Page 3: CMDh-096-2009-Rev2_06_2012.doc

Yours sincerely,

<Signature><Name><Title>

Cover Letter Variation Submission DossierJune 2012, Rev.1 <Procedure Number> <Product Name> Page 3/3